Cardiology | |
|---|---|
| Study Name | Principal Investigator |
| C365101– A phase 2, double-blind, randomized, placebo-controlled, 4-arm study to investigatesymptoms, function, health-related quality of life and safety with repeated subcutaneous administration of Ponsegromab versus placebo in adult participants with heart failure. Read more. |
Angel Mulkay, MD |
| DAPA ACT HF-TIMI 68 – A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Trial to Evaluate the Effect of In-Hospital Initiation of Dapagliflozin on Clinical Outcomes in Patients with Heart Failure with Reduced Ejection Fraction Who Have Been Stabilized During Hospitalization for Acute Heart Failure. Read more. |
Angel Mulkay, MD |
